Novo Nordisk AS (Novo Nordisk), a subsidiary of Novo Holdings AS, is a healthcare company focused on discovering, developing, and manufacturing of innovative biological medicines. It focuses on advancing drugs for the treatment of diabetes and other serious chronic conditions, including hemophilia, human growth hormone (HGH) disorders, and obesity. The company’s portfolio includes pre-filled delivery systems for insulin; glucagon hypokit; cartridge; needles; vials; insulin; estradiol for hormone replacement; recombinant drugs for hemophilia; glucagon; and oral antidiabetic agents. the company markets its products through subsidiaries in North America, Europe, Asia, Latin America, Africa, the Middle East and Australia. Novo Nordisk is headquartered in Bagsvaerd, Denmark.

Headquarters Denmark

Address Novo Alle 1, Bagsvaerd, 2880


Telephone 45 44 448888

No of Employees 49,295

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange NOVO B (CPH)

Revenue (2021) $22.4B 10.9% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 13.3% (2021 vs 2020)

Market Cap* $187.9B

Net Profit Margin (2021) XXX 2.2% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

1,400+

Clinical Trials

Determine Novo Nordisk AS go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

580+

Catalyst Calendar

Proactively evaluate Novo Nordisk AS’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

410+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Novo Nordisk AS’s relevant decision makers and contact details.

170+

Pipeline Drugs

Identify which of Novo Nordisk AS’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

140+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

70+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

50+

Marketed Drugs

Understand Novo Nordisk AS’s commercialized product portfolio to stay one step ahead of the market.

50+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Novo Nordisk AS and assess market opportunity for new entrants with patient population 8-year forecasts.

40+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

30+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

11+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Diabetes Delivery Systems: Tresiba
Insulin pens Ryzodeg
Pre-filled insulin delivery systems Xultophy
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In May, the company and Flagship Pioneering entered into a collaboration to create a portfolio of transformational medicines.
2022 Others In March, Novo Nordisk Foundation awarded grants of DKK 8.8 billion for scientific, humanitarian and social causes.
2022 Contracts/Agreements In March, the company and Health2Sync entered into a partnership to help patients undergoing insulin therapy wirelessly transfer dose logs to a mobile health app.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Novo Nordisk AS Johnson & Johnson Pfizer Inc F. Hoffmann-La Roche Ltd Novartis AG
Headquarters Denmark United States of America United States of America Switzerland Switzerland
City Bagsvaerd New Brunswick New York Basel Basel
State/Province - New Jersey New York - -
No. of Employees 49,295 141,700 79,000 100,920 110,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Helge Lund Chairman Executive Board 2018 60
Lars Fruergaard Jorgensen President; Chief Executive Officer Executive Board 2017 56
Karsten Munk Knudsen Chief Financial Officer; Executive Vice President Senior Management 2018 51
Marcus Schindler Head - Research & Early Development; Executive Vice President; Chief Scientific Officer Senior Management 2021 56
Jeppe Christiansen Vice Chairman Executive Board 2013 63
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer